Cory Klippsten, founder of Swan Bitcoin, warned that artificial intelligence (AI) presents a more immediate threat to Bitcoin's security than quantum computing. He explained that hackers are using AI-driven large language models to identify vulnerabilities in crypto systems. Klippsten believes that quantum computers capable of breaking Bitcoin's cryptography are at least a decade away, and Bitcoin could adopt quantum-resistant protections if needed. He also emphasized the importance of strong security practices by crypto companies to protect customer assets. This view contrasts with Coinbase CEO Brian Armstrong, who sees quantum computing as the bigger long-term risk.
Swan Bitcoin founder's view on AI and Bitcoin security is context for crypto markets. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 03, 2026 09:02 WIB: Out of 50 major cryptocurrencies, 5 rose and 44 fell. ALGO fell 4.18% to Rp1.650 with 87% sell orders, SAND dropped 4.08% to Rp806 with balanced buy/sell activity, and THETA declined 3.73% to Rp2.733 with 100% buy orders.
The Geely E2 (EX2) electric car has reached one million units sold globally within two years of its launch in October 2024, marking rapid market acceptance. It became the world's best-selling car in A&B segments in 2025 and topped sales charts in cou...
AI data centers are expanding beyond traditional land-based locations due to increasing power and space constraints. Companies like Aikido Technologies are exploring floating data centers powered by offshore wind, while Elon Musk's SpaceX plans to de...
Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...
Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
